BioCentury | Jul 31, 2020
Distillery Therapeutics

Targeting the metabolic enzyme DGAT1 to treat glioblastoma

...2020 doi:10.1016/j.cmet.2020.06.002 CONTACT: Deliang Guo, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio email: deliang.guo@osumc.edu Claire Quang The Ohio State University...
BioCentury | Jul 23, 2020
Deals

July 22 Quick Takes: BioNTech raises $512M; plus Vesigen, Quantro, Cullinan, TransThera, JW-Syracuse, AnHeart-NewG

...and other cancers using an immune conjugate platform discovered and developed by scientific founder and Ohio State University...
BioCentury | Jun 23, 2020
Distillery Therapeutics

CDKL5 identified as target in acute kidney injury

...online April 21, 2020 doi:10.1038/s41467-020-15638-6 CONTACT: Navjot Singh Pabla, The Ohio State University, Columbus, Ohio email: pabla.2@osu.edu Claire Quang Ohio State University Cyclin...
BioCentury | Jun 4, 2019
Distillery Techniques

Gemcitabine, Jevtana and Jakavi identified to treat pediatric AML

...C. et al. Nat. Commun. ; published online May 16, 2019 doi:10.1038/s41467-019-09917-0 CONTACT: Christina D. Drenberg, Ohio State University...
...#), INCB018424 (Compound #), INC424 (Compound #), ruxolitinib (Generic), Jakavi (Other), Jakafi (Other) Jevtana, cabazitaxel (XRP6258, xrp-6258) Ohio State University Janus...
BioCentury | Apr 1, 2019
Company News

Management tracks: AACR, Acadia, Aerie

...the Institute for Genomics Medicine at Nationwide Children’s Hospital and a professor of pediatrics at Ohio State University...
BioCentury | Mar 29, 2019
Targets & Mechanisms

Next-wave targets at AACR 2019 start filling the blanks in the tumor microenvironment

...Antonio Proteasome subunit beta 9 (PSMB9; LMP2) PDAC In silico Targeting PSMB9 could help treat PDAC. Ohio State University...
BioCentury | Feb 22, 2019
Targets & Mechanisms

Solid checkpoint for CARs

...versus healthy tissue is enough to avoid toxicity. Timothy Cripe, a professor of pediatrics at Ohio State University...
...is it’s widely expressed on normal tissues and you need a good therapeutic window." Timothy Cripe, Ohio State University...
...Center, New York, N.Y. Miltenyi Biotec GmbH, Bergisch Gladbach, Germany Nationwide Children’s Hospital, Columbus, Ohio Ohio State University...
BioCentury | Feb 14, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: January 2019

...mouse studies suggest promoting WWOX expression could help treat metastatic triple-negative breast cancer (TNBC) The Ohio State University...
BioCentury | Feb 8, 2019
Company News

Verily launches OneFifteen to create tech-forward solutions for addiction

...led by Marti Taylor, former CEO of University Hospital and the Ross Heart Hospital at Ohio State University...
BioCentury | Jan 23, 2019
Distillery Therapeutics

Cancer

...online Jan. 8, 2019 doi:10.1158/0008-5472.CAN-18-0614 CONTACT: Rami I. Aqeilan, The Ohio State University, Columbus, Ohio email: ramiaq@ekmd.huji.ac.il Claire Quang Ohio State University WW...
Items per page:
1 - 10 of 184
BioCentury | Jul 31, 2020
Distillery Therapeutics

Targeting the metabolic enzyme DGAT1 to treat glioblastoma

...2020 doi:10.1016/j.cmet.2020.06.002 CONTACT: Deliang Guo, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio email: deliang.guo@osumc.edu Claire Quang The Ohio State University...
BioCentury | Jul 23, 2020
Deals

July 22 Quick Takes: BioNTech raises $512M; plus Vesigen, Quantro, Cullinan, TransThera, JW-Syracuse, AnHeart-NewG

...and other cancers using an immune conjugate platform discovered and developed by scientific founder and Ohio State University...
BioCentury | Jun 23, 2020
Distillery Therapeutics

CDKL5 identified as target in acute kidney injury

...online April 21, 2020 doi:10.1038/s41467-020-15638-6 CONTACT: Navjot Singh Pabla, The Ohio State University, Columbus, Ohio email: pabla.2@osu.edu Claire Quang Ohio State University Cyclin...
BioCentury | Jun 4, 2019
Distillery Techniques

Gemcitabine, Jevtana and Jakavi identified to treat pediatric AML

...C. et al. Nat. Commun. ; published online May 16, 2019 doi:10.1038/s41467-019-09917-0 CONTACT: Christina D. Drenberg, Ohio State University...
...#), INCB018424 (Compound #), INC424 (Compound #), ruxolitinib (Generic), Jakavi (Other), Jakafi (Other) Jevtana, cabazitaxel (XRP6258, xrp-6258) Ohio State University Janus...
BioCentury | Apr 1, 2019
Company News

Management tracks: AACR, Acadia, Aerie

...the Institute for Genomics Medicine at Nationwide Children’s Hospital and a professor of pediatrics at Ohio State University...
BioCentury | Mar 29, 2019
Targets & Mechanisms

Next-wave targets at AACR 2019 start filling the blanks in the tumor microenvironment

...Antonio Proteasome subunit beta 9 (PSMB9; LMP2) PDAC In silico Targeting PSMB9 could help treat PDAC. Ohio State University...
BioCentury | Feb 22, 2019
Targets & Mechanisms

Solid checkpoint for CARs

...versus healthy tissue is enough to avoid toxicity. Timothy Cripe, a professor of pediatrics at Ohio State University...
...is it’s widely expressed on normal tissues and you need a good therapeutic window." Timothy Cripe, Ohio State University...
...Center, New York, N.Y. Miltenyi Biotec GmbH, Bergisch Gladbach, Germany Nationwide Children’s Hospital, Columbus, Ohio Ohio State University...
BioCentury | Feb 14, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: January 2019

...mouse studies suggest promoting WWOX expression could help treat metastatic triple-negative breast cancer (TNBC) The Ohio State University...
BioCentury | Feb 8, 2019
Company News

Verily launches OneFifteen to create tech-forward solutions for addiction

...led by Marti Taylor, former CEO of University Hospital and the Ross Heart Hospital at Ohio State University...
BioCentury | Jan 23, 2019
Distillery Therapeutics

Cancer

...online Jan. 8, 2019 doi:10.1158/0008-5472.CAN-18-0614 CONTACT: Rami I. Aqeilan, The Ohio State University, Columbus, Ohio email: ramiaq@ekmd.huji.ac.il Claire Quang Ohio State University WW...
Items per page:
1 - 10 of 184